Morgan Stanley Has Lowered Expectations for Ardent Health Partners (NYSE:ARDT) Stock Price

Ardent Health Partners (NYSE:ARDT) had its price target reduced by research analysts at Morgan Stanley from $23.50 to $22.00 in a report released on Tuesday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Morgan Stanley’s price target indicates a potential upside of 57.14% from the stock’s current price.

Several other equities analysts have also recently issued reports on the company. Leerink Partners boosted their price objective on Ardent Health Partners from $23.00 to $25.00 and gave the company an “outperform” rating in a report on Tuesday, November 12th. KeyCorp initiated coverage on Ardent Health Partners in a research report on Friday, October 11th. They issued an “overweight” rating and a $24.00 price target for the company. Bank of America lowered Ardent Health Partners from a “buy” rating to a “neutral” rating and dropped their price target for the company from $22.00 to $19.00 in a research report on Wednesday, November 6th. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $20.00 price objective on shares of Ardent Health Partners in a research report on Tuesday, December 17th. Finally, Royal Bank of Canada restated an “outperform” rating and set a $23.00 price target on shares of Ardent Health Partners in a research report on Thursday, November 14th. Two investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $21.55.

Ardent Health Partners Trading Down 0.7 %

Shares of ARDT traded down $0.10 during trading hours on Tuesday, hitting $14.00. The company had a trading volume of 147,542 shares, compared to its average volume of 267,605. Ardent Health Partners has a one year low of $13.63 and a one year high of $20.72. The business’s fifty day moving average price is $16.22. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78.

Institutional Investors Weigh In On Ardent Health Partners

A number of hedge funds and other institutional investors have recently modified their holdings of ARDT. State Street Corp purchased a new stake in shares of Ardent Health Partners during the 3rd quarter valued at $1,977,000. Jane Street Group LLC acquired a new stake in Ardent Health Partners during the third quarter worth about $567,000. Allspring Global Investments Holdings LLC acquired a new stake in Ardent Health Partners during the third quarter worth about $13,119,000. Goldentree Asset Management LP bought a new stake in shares of Ardent Health Partners during the third quarter valued at approximately $22,897,000. Finally, Geode Capital Management LLC acquired a new position in shares of Ardent Health Partners during the third quarter valued at approximately $2,581,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.